April 27, 2012 — Amidst growing concerns over healthcare costs, the Society of Nuclear Medicine (SNM) is offering a solution to help cut back on federal spending in its new report, “Imaging with CARE.” According to the report, an estimated $1.32 billion could be saved on nuclear and molecular imaging procedures over the next 10 years by taking steps to reduce the number of repeated scans due to poor quality images.

Approximately 130 million diagnostic radiology procedures—including X-rays, magnetic resonance imaging (MRI), computed tomography (CT) and nuclear medicine scans—are performed on 30 million Medicare enrollees each year. According to the Government Accountability Office, nuclear and molecular imaging scans account for $2.4 billion in costs. With an estimated four to seven percent of these procedures repeated due to poor imaging, Medicare spends $132 million in avoidable scans each year.

“Having to repeat a nuclear or molecular imaging scan because of the poor quality of the original image is something that shouldn’t happen and something that can be fixed,” said Ann Marie Alessi, BS, CNMT, NCT, RT(N), president of SNM’s Technologist Section. “By ensuring that the technologists performing these scans have appropriate training and education, Congress can ensure that most of these repeated scans are avoided.”

Each year an estimated 17 million nuclear medicine and molecular imaging procedures are performed in hospitals and medical settings across the United States. Nuclear medicine procedures use radioactive substances to visualize the molecular processes through which the body functions. This provides physicians with unique data that can help personalize treatment for heart disease, cancer, brain disorders and other diseases.

Currently only 30 states and the District of Columbia[1] have certification or licensure provisions for nuclear medicine and molecular imaging technologists that require them to be certified by a national credentialing organization. Twenty states[2] do not regulate this profession at all.

“Many state regulations also include continuing education requirements,” added Alessi. “With new technologies upon us every year, it’s critical that nuclear medicine and molecular imaging technologists are up-to-date on the techniques needed to appropriately perform the imaging scans.”

Poor quality scans can also result in misdiagnosis of disease, delays in treatment and unnecessary anxiety for the patient. If additional testing is required, patients are exposed to an increased amount of radiation. While imaging can be an invaluable tool, the procedures do carry a potential health risk, and radiation can be harmful if administered improperly.

To improve the quality of medical imaging, the Consistency, Accuracy, Responsibility and Excellence in Medical Imaging (CARE) bill has been introduced in Congress. If enacted, the bill would establish minimum education and certification standards for personnel who perform nuclear medicine and molecular imaging procedures. As a result, institutions that provide medical imaging or radiation therapy to Medicare patients would be required to employ personnel who meet or exceed the standards set by the federal government.

The CARE bill is supported by the Alliance for Quality Medical Imaging and Radiation Therapy, a group co-founded by SNM, its Technologist Section and the American Society of Radiologic Technologists in 1998. Since then, an additional 20 organizations have joined the alliance; together, the 23 groups represent more than 500,000 health care professionals. The bill currently has 89 co-sponsors, and it is expected that companion legislation will be introduced in the U.S. Senate.

For more information: www.snm.org/CARE

1 Arizona, Arkansas, California, Delaware, District of Columbia, Florida, Hawaii, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Mississippi, New Jersey, New Mexico, New York, Ohio, Oregon, Pennsylvania, Rhode Island, South Carolina, Texas, Utah, Vermont, Washington, West Virginia, Wyoming.

2 Alabama, Alaska, Colorado, Connecticut, Georgia, Idaho, Michigan, Minnesota, Missouri, Montana, Nebraska, Nevada, New Hampshire, North Carolina, North Dakota, Oklahoma, South Dakota, Tennessee, Virginia, Wisconsin.


Related Content

News | Prostate Cancer

July 30, 2024 — Blue Earth Diagnostics, a Bracco company and recognized leader in the development and commercialization ...

Time July 30, 2024
arrow
News | Radiopharmaceuticals and Tracers

July 25, 2024 — NorthStar Medical Radioisotopes, LLC and BWXT Medical Ltd., a subsidiary of BWX Technologies, Inc ...

Time July 25, 2024
arrow
News | PET-CT

July 25, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET & PET-CT imaging ...

Time July 25, 2024
arrow
News | Computed Tomography (CT)

July 15, 2024 — NeuroLogica Corp, a subsidiary of Samsung Electronics Co. Ltd., announced its latest configuration of ...

Time July 15, 2024
arrow
News | Prostate Cancer

July 5, 2024 — Lantheus Holdings, Inc., a leading radiopharmaceutical-focused company committed to enabling clinicians ...

Time July 05, 2024
arrow
News | Prostate Cancer

July 2, 2024 — A new editorial paper was published in Oncoscience (Volume 11) on May 20, 2024, entitled, “Deep learning ...

Time July 02, 2024
arrow
News | ASTRO

June 21, 2024 — The American Society for Radiation Oncology (ASTRO) announced today that following a nationwide search ...

Time June 21, 2024
arrow
News | Nuclear Imaging

June 20, 2024 — GE HealthCare joined the world’s top medical and academic institutions at the Society of Nuclear ...

Time June 20, 2024
arrow
News | Proton Therapy

June 14, 2024 — Atlantic Health System, an integrated health care system setting standards for quality health care in ...

Time June 14, 2024
arrow
News | PET Imaging

June 14, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 14, 2024
arrow
Subscribe Now